ACTU Q1 2026 Earnings EPS Miss Weighs on Shares as Biotech Firm Navigates EarlyStage Pipeline ClearOne CLRO Q2 2018 Earnings Narrowing Losses Exceeds Analyst Expectations PMCB Q1 2026 Earnings PreRevenue Biotech Reports Negative EPS Stock Rises on Potential Pipeline Progress Qorvo Q1 2026 Earnings Strong EPS Beat Drives Positive Market Reaction VUZI Q1 2026 Earnings EPS Surprises Positively Amid Ongoing Challenges BTMD Q1 2026 Earnings EPS Beats Estimates by 2371 Amid Revenue Discrepancy